Woodline Partners LP Vaxcyte, Inc. Transaction History

Woodline Partners LP

$11 Billion
Q3 2024

A detailed history of Woodline Partners LP transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 1,103,945 shares of PCVX stock, worth $102 Million. This represents 1.14% of its overall portfolio holdings.

Number of Shares

1,103,945

Previous 706,903 56.17%

Holding current value

$102 Million

Previous $53.4 Million 136.12%

% of portfolio

1.14%

Previous 0.54%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$70.52 - $117.12 $28 Million - $46.5 Million	397,042 Added 56.17%	1,103,945 $126 Million
Q2 2024 Aug 14, 2024	BUY	$60.06 - $78.77 $18.8 Million - $24.7 Million	313,199 Added 79.55%	706,903 $53.4 Million
Q1 2024 May 15, 2024	BUY	$59.79 - $81.05 $21,105 - $28,610	353 Added 0.09%	393,704 $26.9 Million
Q4 2023 Feb 14, 2024	BUY	$45.35 - $63.41 $577,668 - $807,716	12,738 Added 3.35%	393,351 $24.7 Million
Q3 2023 Nov 14, 2023	SELL	$46.0 - $53.1 $452,778 - $522,663	-9,843 Reduced 2.52%	380,613 $19.4 Million
Q2 2023 Aug 14, 2023	BUY	$34.66 - $54.07 $4.87 Million - $7.59 Million	140,456 Added 56.18%	390,456 $19.5 Million
Q4 2022 Feb 14, 2023	BUY	$20.58 - $47.95 $1.1 Million - $2.57 Million	53,571 Added 27.27%	250,000 $12 Million
Q3 2022 Nov 14, 2022	SELL	$21.69 - $28.53 $5.85 Million - $7.7 Million	-269,895 Reduced 57.88%	196,429 $4.71 Million
Q2 2022 Aug 15, 2022	BUY	$17.68 - $26.58 $8.24 Million - $12.4 Million	466,324 New	466,324 $10.1 Million
Q1 2022 May 16, 2022	SELL	$17.46 - $26.36 $1.7 Million - $2.57 Million	-97,396 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$19.32 - $26.45 $1.88 Million - $2.58 Million	97,396 New	97,396 $2.32 Million
Q3 2020 Nov 16, 2020	SELL	$26.5 - $55.4 $610,189 - $1.28 Million	-23,026 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$26.15 - $35.45 $602,129 - $816,271	23,026 New	23,026 $728,000

Others Institutions Holding PCVX

# of Institutions

348

Shares Held

123M

Call Options Held

748K

Put Options Held

411K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $5.5B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Vaxcyte, Inc. Transaction History